The urinary catheters market is expected to experience significant growth in the coming years. Urinary catheters are medical devices used to drain urine from the bladder when normal urine flow is impeded, such as in the case of urinary retention or urinary incontinence.
The market is segmented into intermittent catheters, Foley catheters, and external catheters. The Foley catheter segment accounts for the largest market share due to its widespread use in hospitals and clinics. Intermittent catheters are expected to grow at a higher rate due to their advantages such as lower risk of infection and reduced catheter-associated urinary tract infections (CAUTI).
The major drivers of the urinary catheters market include the increasing prevalence of urinary disorders such as urinary incontinence and urinary retention, along with a growing elderly population. The rise in chronic diseases such as diabetes and obesity has also contributed to the growth of the market.
Geographically, North America and Europe dominate the market due to the high prevalence of urinary disorders in these regions. However, the Asia Pacific region is expected to experience the highest growth rate due to the increasing aging population and rising awareness of urinary disorders.
The market is highly competitive, with major players such as B. Braun Melsungen AG, Coloplast A/S, and ConvaTec Group PLC. These companies are investing in research and development to introduce new products and improve existing ones. The market is also witnessing partnerships and collaborations among companies to expand their product portfolio and increase their market share.
In conclusion, the urinary catheters market is expected to continue growing due to the increasing prevalence of urinary disorders and a growing aging population. The market is highly competitive, with major players investing in research and development to introduce new products and improve existing ones. Intermittent catheters are expected to grow at a higher rate due to their advantages such as lower risk of infection and reduced CAUTI.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.